InsidersTradesSigma
Track the 삼아제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼아제약 has recorded 1 public disclosures. Market capitalisation: €74.6bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 삼아제약. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samah Pharmaceutical es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos. Cotiza en el mercado XKRX.